SPC Logo

Cosopt Ophthalmic Solution

Last Updated on eMC 03-Jul-2014 View document  | Merck Sharp & Dohme Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03-Jul-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 15-Aug-2012 and displayed until 03-Jul-2014

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation

Updated on 25-May-2012 and displayed until 15-Aug-2012

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors

Updated on 17-Jun-2010 and displayed until 25-May-2012

Reasons for adding or updating:

  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 16-Feb-2010 and displayed until 17-Jun-2010

Reasons for adding or updating:

  • Change to storage instructions

Updated on 03-Jul-2009 and displayed until 16-Feb-2010

Reasons for adding or updating:

  • Correction of spelling/typing errors
  • Extra statutory information

Updated on 29-Jun-2009 and displayed until 03-Jul-2009

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 15-Jun-2009 and displayed until 29-Jun-2009

Reasons for adding or updating:

  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information

Updated on 13-Aug-2008 and displayed until 15-Jun-2009

Reasons for adding or updating:

  • Change to drug interactions

Updated on 25-May-2007 and displayed until 13-Aug-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Updated on 05-Feb-2004 and displayed until 25-May-2007

Reasons for adding or updating:

  • Update to PIL

Updated on 18-Feb-2003 and displayed until 05-Feb-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 25-Jul-2002 and displayed until 18-Feb-2003

Reasons for adding or updating:

  • Update to PIL

Updated on 31-Oct-2001 and displayed until 25-Jul-2002

Reasons for adding or updating:

  • Update to PIL

Updated on 18-Jul-2001 and displayed until 31-Oct-2001

Reasons for adding or updating:

  • Update to PIL

Updated on 17-Aug-2000 and displayed until 18-Jul-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Merck Sharp & Dohme Limited

Company image
Address

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU

Fax

+44 (0)1992 479 292

Stock Availability

Call MSD customer services on 01992 452094

Telephone

+44 (0)1992 467 272

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

dorzolamide hydrochloride, timolol maleate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.